Neimeth Shareholder Buys 74.7 Million Shares in ₦448.36 Million Transaction

Neimeth Shareholder Clinoscope Buys 74.7 Million Shares for ₦448.36 Million
Executive summary
Clinoscope Services Limited, identified in a regulatory notification as a substantial shareholder of Neimeth International Pharmaceuticals Plc, purchased 74,726,661 ordinary shares at ₦6.00 per share in a transaction executed in Lagos on 10 November 2026. Neimeth’s notification was dated and submitted to the Nigerian Exchange on 13 November 2026. The disclosed quantity and price imply a transaction value of ₦448.36 million. The filing does not state Clinoscope’s holding before or after the purchase, the seller, or the resulting percentage ownership.

Clinoscope Services Limited, a substantial shareholder in Neimeth International Pharmaceuticals Plc, has purchased 74.73 million ordinary shares in the pharmaceutical company at ₦6.00 per share, in a transaction valued at approximately ₦448.36 million. The deal took place in Lagos on 10 November and was disclosed to the Nigerian Exchange in a notification dated 13 November 2026.
Company background
Neimeth International Pharmaceuticals Plc is listed on the NGX Main Board under the ticker NEIMETH. The Exchange’s company profile classifies it in the healthcare sector and pharmaceuticals sub-sector. Its stated business covers the manufacture and marketing of pharmaceutical products, animal-health products and general healthcare products.
What the filing says
The one-page notification is titled “Notification of Share Dealing by an Insider”. It identifies Clinoscope Services Limited as the insider and describes its position as a substantial shareholder. The notification records an initial filing, a purchase of ordinary shares with ISIN NGNEIMETH001, an aggregate volume of 74,726,661 units, an average price of ₦6.00 per share, and a transaction date of 10 November 2026. Lagos is stated as the place of transaction. The filing was signed by Neimeth Company Secretary Chinenye S. Adekanmbi.
Multiplying the disclosed volume by the disclosed price gives an implied value of ₦448,359,966. This is an arithmetic calculation, not a separately stated consideration in the document.
Business and financial implications
The notification records a share purchase, not a new capital issue, rights offer or fundraising by Neimeth. It does not disclose any proceeds payable to the company. On the information available, the transaction should therefore be treated primarily as a change in the ownership of shares rather than a direct improvement in Neimeth’s cash position, revenue or earnings. The filing does not identify the seller or specify whether the purchase was executed on the exchange or through another permitted transaction route.
The purchase may affect the distribution of ownership and can be relevant to investors monitoring substantial-shareholder activity. However, the notification alone does not establish the purchaser’s motivation, indicate a change in control, or provide evidence of future operating performance.
Investor perspective
Investors should note the scale of the disclosed purchase and the fact that the purchaser is identified as a substantial shareholder. The filing does not provide Clinoscope’s pre-transaction balance, post-transaction shareholding, or percentage of issued capital. Those omissions prevent a reliable calculation of its resulting ownership stake or the extent to which its position changed. The disclosure should not be interpreted on its own as a buy signal or as confirmation of improved company fundamentals.
The next useful checks are any subsequent substantial-shareholding notification, changes in Neimeth’s free-float or ownership disclosures, and the company’s next financial statements. No forecast or valuation conclusion is warranted from this transaction notice alone.
Conclusion
Clinoscope’s purchase of 74.73 million Neimeth shares represents a sizeable disclosed transaction, with an implied value of ₦448.36 million. The filing confirms the buyer’s status as a substantial shareholder and the transaction’s date, volume and price. It leaves important ownership details unanswered, so investors should treat it as a material ownership disclosure rather than evidence of a direct cash injection, a change in control or a forecast of Neimeth’s financial performance.
Key facts
- • Buyer: Clinoscope Services Limited, described in the filing as a substantial shareholder.• Shares purchased: 74,726,661 ordinary shares.• Price: ₦6.00 per share.• Implied value: ₦448,359,966, calculated from the disclosed volume and price.• Transaction date: 10 November 2026; place: Lagos.• NGX notification date: 13 November 2026.• The filing does not state the seller or the buyer’s resulting percentage holding.


